Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
It comes following the online spat between Musk and OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by the president earlier this week, who described ...
The prime minister’s bumbling answer to a press club question on Australia’s engagement in the AI arms race shows how ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...
Chinese start-up DeepSeek is as powerful as ChatGPT and purportedly uses much less computing power. Will this competition ...
ChatGPT became inaccessible for millions of users worldwide, showing a 'bad gateway error'. OpenAI promptly issued a fix.